Business

Glenmark launches cheaper SGLT2 inhibitor class of anti-diabetes drug in India

Glenmark launches cheaper SGLT2 inhibitor class of anti-diabetes drug in India The drug, generically called as Remogliflozin etabonate, is used in the treatment of type-2 diabetes mellitus in adults.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts